Research is finding that there is an intricate connection between sleep and inflammation, such that lack of sleep can increase inflammation, noted Andrew McHill, PhD, an assistant professor at Oregon Health and Science University.
Research is finding that changing blood pressure responses from shift work may be due to increased sympathetic activity and that there is an intricate connection between sleep and inflammation, such that lack of sleep can increase inflammation, noted Andrew McHill, PhD, an assistant professor at Oregon Health and Science University.
McHill is an author on 5 abstracts presented at SLEEP 2023 that investigate the impact of sleep patterns and circadian variations on blood pressure and overall health outcomes.
Transcript
Can you elaborate on the interplay between sleep disruption and the body's inflammatory response?
So we know that sleep and inflammation are very intricately connected, such to the point where if you have too much inflammation, it makes it harder to get to sleep or to stay asleep, and if you don't get enough sleep, it can actually increase your inflammation. As far as our findings go, we think it more pertains to the sympathetic activity and increased sympathetic activity with shift work and sleep disruption that is probably changing blood pressure responses when working these shifts.
How do these alterations affect hemodynamic changes observed in blood pressure regulation?
We are very interested in this overnight blood pressure dipping patterns. We know that if your blood pressure dips 10% or greater than what it is during the daytime, that's a very healthy phenotype. However, in some individuals, they don't have this overnight dipping, which has been associated with a whole host of adverse cardiovascular outcomes and premature mortality. So we've been really focusing on this 24-hour blood pressure rhythm, and we find that when individuals transition into shift work or have been working shift work for a long time, they begin to lose this ability to dip their blood pressure at night when they're going to sleep. And so this could be related to a whole host of about adverse outcomes down the road.
Can you provide examples of these adverse outcomes?
Premature mortality, any type of cardiovascular event, heart attack, stroke, it's been tightly associated with all of those 4 outcomes.
I think it's a very exciting time to be in the field of sleep and circadian research, as we are really looking into this kind of personalized approach for sleep hygiene and sleep habits, and looking at novel mechanisms, such as sleep regularity, for improving health. And I think that these mechanisms may be more feasible for an individual. It's easier, I think, probably to tell someone to go to bed at the same time than to tell them to get more sleep, which is a very difficult intervention. By telling someone if you can just try as hard as you can to go to sleep at the same time, I think will be a lot more feasible.
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Budesonide-Based Triple Therapy Shows Best Benefit Over Dual Therapy for COPD
May 8th 2024The triple therapy of budesonide, glycopyrrolate, and formoterol fumarate showed the greatest incremental net benefit among a series of triple therapy medications that were evaluated against dual therapy for chronic obstructive pulmonary disease (COPD), according to an analysis presented at ISPOR.
Read More
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Budesonide-Based Triple Therapy Shows Best Benefit Over Dual Therapy for COPD
May 8th 2024The triple therapy of budesonide, glycopyrrolate, and formoterol fumarate showed the greatest incremental net benefit among a series of triple therapy medications that were evaluated against dual therapy for chronic obstructive pulmonary disease (COPD), according to an analysis presented at ISPOR.
Read More
2 Commerce Drive
Cranbury, NJ 08512